Neuroscientific Biopharmaceuticals (ASX:NSB) OCF Margin %: -285.53% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Neuroscientific Biopharmaceuticals OCF Margin %?

Neuroscientific Biopharmaceuticals ASX:NSB OCF Margin % is -285.53% as of Dec. 2025. The stock has 1 warning sign investors should review. Among 952 Biotechnology companies, Neuroscientific Biopharmaceuticals ranks worse than 71.43% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Neuroscientific Biopharmaceuticals's Cash Flow from Operations for the six months ended in Dec. 2025 was A$-0.91 Mil. Neuroscientific Biopharmaceuticals's Revenue for the six months ended in Dec. 2025 was A$0.32 Mil. Therefore, Neuroscientific Biopharmaceuticals's OCF Margin % for the quarter that ended in Dec. 2025 was -285.53%.

As of today, Neuroscientific Biopharmaceuticals's current OCF Yield % is -5.94%.

The historical rank and industry rank for Neuroscientific Biopharmaceuticals's OCF Margin % or its related term are showing as below:

ASX:NSB' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -436.79

ASX:NSB's OCF Margin % is ranked worse than
71.43% of 952 companies
in the Biotechnology industry
Industry Median: -65.71 vs ASX:NSB: -436.79

Neuroscientific Biopharmaceuticals OCF Margin % Related Terms

Neuroscientific Biopharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Neuroscientific Biopharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuroscientific Biopharmaceuticals OCF Margin % Chart

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -285.53

ASX:NSB vs VRTX, REGN, RVMD: OCF Margin % Comparison

For the Biotechnology subindustry, Neuroscientific Biopharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuroscientific Biopharmaceuticals OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuroscientific Biopharmaceuticals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Neuroscientific Biopharmaceuticals's OCF Margin % falls into.


Neuroscientific Biopharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Neuroscientific Biopharmaceuticals's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-0.941/0
= %

Neuroscientific Biopharmaceuticals's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.908/0.318
=-285.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -285.53% mean?
Neuroscientific Biopharmaceuticals (ASX:NSB) has a OCF Margin % of -285.53% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Neuroscientific Biopharmaceuticals and its competitors. According to the industry distribution chart, Neuroscientific Biopharmaceuticals ranks #680 out of 952 companies in the Biotechnology industry, placing it in the top 71.4%.
Is Neuroscientific Biopharmaceuticals' OCF Margin % too high?
Neuroscientific Biopharmaceuticals' current OCF Margin % is -285.53%. Based on the distribution chart, Neuroscientific Biopharmaceuticals ranks #680 out of 952 companies in the Biotechnology industry, which is below the industry midpoint.
How does Neuroscientific Biopharmaceuticals' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Neuroscientific Biopharmaceuticals ranks #680 out of 952 companies for OCF Margin %. This places Neuroscientific Biopharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Neuroscientific Biopharmaceuticals and its competitors. Neuroscientific Biopharmaceuticals's current OCF Margin % is -285.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuroscientific Biopharmaceuticals stock overvalued right now?
Neuroscientific Biopharmaceuticals (ASX:NSB) has a current OCF Margin % of -285.53%. The current OCF Margin % is -285.53%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Neuroscientific Biopharmaceuticals (ASX:NSB), the current OCF Margin % is -285.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neuroscientific Biopharmaceuticals Business Description

Address 216 Street Georges Terrace, Level 4, Perth, WA, AUS, 6000
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and treatments for neurodegenerative diseases through preclinical studies of patented technologies.